A study published in JAMA found that nearly 28% of newly infected people have a strain of HIV resistant to at least one class of antiretroviral drugs, highlighting the need for new treatment options. The research also shows that drug-resistant viruses take longer to control with current treatments.
A Johns Hopkins Medicine study reveals that HIV treatment is equally effective for patients with both HIV and hepatitis C infections, contrary to previous assumptions. The research found no significant difference in the virologic or immunologic response to HAART among those with co-infection, suggesting hepatitis C infection should not...
Northwestern researcher Robert L. Murphy calls for simplified, less toxic HIV therapies due to complex regimens and adverse effects. He discusses potential new treatments like atazanavir, a single-daily-dose protease inhibitor with minimal side effects.
Researchers found that drug combinations significantly reduced HIV levels in untreated patients, with at least 75% achieving a viral load of less than 400 copies/mL after 48 weeks. The study used three different drug combinations and found impressive changes in viral loads across all groups.
Researchers found that nucleic acid testing can identify acute HIV infection in people who are most contagious, missing routine antibody tests. This can help prevent further transmission and improve long-term prognosis for those diagnosed early.
Scientists followed nearly 2,000 HIV-infected patients with varying levels of hepatitis C exposure. They found that exposure to hepatitis C did not increase risk of death or AIDS progression but was associated with lower antiretroviral therapy prescriptions, which may lead to increased mortality rates in this group.